The Use of Synthetic Oligonucleotides as Protein Inhibitors and Anticode Drugs in Cancer Therapy: Accomplishments and Limitations

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|2|4|355-368

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.2, Iss.4, 2002-12, pp. : 355-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1804-1820

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Protein Tyrosine Phosphatase Inhibitors as Promising Targeted Therapeutic Drugs

By  

Current Medicinal Chemistry, Vol. 16, Iss. 6, 2009-02 ,pp. : 706-733

Bentham Science Publishers

Access to resources Recommend Favorite

New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy

By  

Current Drug Targets, Vol. 15, Iss. 9, 2014-08 ,pp. : 843-851

Bentham Science Publishers

Access to resources Recommend Favorite

Progress Towards Therapeutic Small Molecule MEK Inhibitors for Use in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 215-229

Bentham Science Publishers

Access to resources Recommend Favorite

Natural and Synthetic Inhibitors of Caspases: Targets for Novel Drugs

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 333-340

Bentham Science Publishers

Access to resources Recommend Favorite